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We review the literature to appraise the evidence supporting or disputing the use of eye
movement measurement in disorders of consciousness (DOC) with low levels of arousal or
awareness, such as minimally conscious state (MCS), vegetative state (VS), and coma for
diagnostic and prognostic purposes. We will focus on the effectiveness of each technique
in the diagnostic classification of these patients and the gradual trend in research from
manual to computerized tracking methods. New tools have become available at clinicians’
disposal to assess eye movements with high spatial and temporal fidelity. The close rela-
tionship between eye movement generation and organic dysfunction in the brain allows
these tools to be applied to the assessment of severe DOC as a unique supplementary
toolset. We posit that eye tracking can improve clinical diagnostic precision for DOC, a key
component of assessment that often dictates the course of clinical care in DOC patients.
We see the emergence of long-term eye-tracking studies with seamless integration of
technology in the future to improve the performance of clinical assessment in DOC.
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REVIEW
INTRODUCTION
There are little means by which a clinician can assess and prog-
nose clinical course in severe cases of disorders of consciousness
(DOC), limiting effective care of patients. Furthermore, caregivers
for DOC patients experience a higher level of anxiety, depres-
sion, and maladaptive psychological states compared with control
participants and with themselves at the beginning of their caregiv-
ing period (1, 2). From both perspectives, it is important to have
effective tools to make the best clinical decisions.
Disorders of consciousness are divided into several domains.
Locked-in syndrome, minimally conscious state (MCS), vegeta-
tive state (VS), and coma are four major classifications (3). Each
category of DOC is associated with its own clinical course and
prognosis. Categorization of DOC has been repeatedly invaluable
from a clinical perspective to make practical decisions about life
support, palliative care, and/or treatment plan, but theory suggests
that self-referential states such as consciousness are produced by
coordinated diffuse network activations integrating multiple sets
of different nuclei in the brain (4). If this is a reliable and accu-
rate model, damage which significantly reduces consciousness will
likely affect the brain areas necessary for successful eye movement.
Quantifying this neurological damage may be useful and requires
more than the simple qualitative appraisals of eye, sensory, and
motor function.
The clinical gold standard for diagnosis of DOC is bedside
behavioral assessment, in-hospital observation, and specialized
robust scales such as the Coma Recovery Scale-Revised (CRS-R)
(5), and neurocognitive assessment in advanced stages of recov-
ery (6). Research has shown that neurophysiological monitoring
may also be useful (7). The diagnosis from this assessment then
dictates the clinical treatment plan and patient prognosis. How-
ever, it is difficult to make accurate decisions, partly due to the
limited responsiveness and arousal of the patients, and partly due
to the specialized training necessary to conduct a thorough neuro-
logical exam, and interpret neuroimaging and electrophysiology.
A clinically standardized tool in the form of an eye movement
measurement device, easily accessible and interpretable by all staff
involved in the DOC patient’s care would help to supplement
patient care. There are estimates of up to 40% misdiagnosis rate
betweenVS and MCS (8). Traditionally, eye assessment in DOC has
been limited to simple assessment of eye response. An acute care
physician may look at opening or closing of the eyes in response
to stimuli, pupil response to light, blink reflex, or the direction
of spontaneous movement as part of clinical workup depending
on the level of consciousness of the patient. Beyond qualitative
appraisal, however, there are many more parameters of eye move-
ments, such as their velocity, accuracy, and error rate, which can
be easily measured with the right machines and may provide valu-
able diagnostic and prognostic information that is not currently
considered by physicians during clinical workup.
Published in 1974, the Glasgow Coma Scale (GCS) qualitatively
assesses eye, motor, and verbal responses with a maximum score
of 15 indicating full arousal and awareness (9). Despite being the
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most commonly used assessment of conscious state today (10),
outcome measures for the eye response component are limited to
eye opening or closing in response to simple stimuli (9). The GCS
is an example where advanced eye-tracking technology can pro-
vide much richer and detailed information, which could be used
in conjunction with existing techniques for more refined diag-
nosis and accurate prognosis of severe DOC. The GCS score is
also an easily accessible system for all personnel involved in the
patient’s circle of care, and this has been reflected in the creation
of clinical diagrams and visual flowcharts. Although no standard-
ized equivalent exists for eye movements at the moment, as the
technology is validated and more widely adopted, it is likely that
similar resources would be created to lower the barrier to adoption
for most health care personnel.
Further development of eye tracking and recording technology
in the mid-1990s to sufficient temporal and spatial fidelity was
needed before useful information could be obtained from record-
ings to make an informed assessment. Today, these eye trackers are
commonplace in research of severe neurological disorders rang-
ing from multiple sclerosis (11) to visuospatial neglect (12). The
current research standard is the full desktop, which is limited in
portability despite its power. Slowly, we are seeing the emergence of
portable machines, which are worn on the head and able to mea-
sure eye movements on the sub-millisecond and sub-millimeter
scale. Although this eye-tracking technology is used extensively in
research, it is not used for clinical decision making.
The neuroanatomy responsible for many eye movements is
well characterized in primates and humans (13–18). In humans,
ocular motion is controlled by three sets of oculomotor muscles
(15). Although they are the ultimate effectors of eye movement,
computation for simple eye movements like saccades occurs over
many levels of neural control connecting the cerebral cortices,
through the midbrain structures, down to the lower brainstem
where the desired eye movement is integrated and the final signal
is issued (19).
Hence, an intricate connection exists between eye movement
pathology and DOC. Generation of successful eye movements
and a fully conscious state with high levels of arousal and aware-
ness both depend on coordinated activity between multiple levels
of neural control centers, including the cerebral cortex capable
of modulating activity in most systems below it, the subcortical
nuclei, midbrain and lower brainstem nuclei. Many studies have
suggested that DOC may be reflected in eye movement pathol-
ogy due to disruptions in these sensitive structural and functional
connections.
Our knowledge of the neuroanatomy involved in DOC,
although still young, has made great progress mainly through
advances in functional neuroimaging of DOC patients (20,
21). Relatively novel techniques such as susceptibility/diffusion
weighted imaging (S/DWI) and diffusion tensor imaging (DTI)
have enhanced sensitivity to fine structural damage than canonical
techniques (computerized tomography for example). Functional
neuroimaging has quickly flourished and can assess transient fluc-
tuations in regional cerebral blood flow and perfusion in the brain
as well as functional integrity through neural connections, which
may appear structurally intact otherwise. Advanced neuroimag-
ing has been reviewed extensively as a tool to assess DOC and
shows promise (20–25), but current clinical evaluation tools out-
side of neuroimaging remain limited in scope and power. Not all
healthcare facilities have the financial resources and expertise to
use neuroimaging for DOC assessment, but eye trackers are read-
ily available, have lower cost of procurement, and are relatively
more portable than MRI scanners. Eye movement measurement
can therefore be a complementary evaluation tool for patients with
severe DOC, or an alternative when the necessary neuroimaging
resources are not available.
VESTIBULO-OCULAR REFLEX
The vestibular system and associated vestibulo-ocular reflex is well
characterized (26). In DOC research, two different approaches
have been used to elicit VOR. The traditional method is with
caloric stimulation (27–33), in which warm or cold water is poured
into the auditory canal unilaterally and quick phases of nystagmus
are observed. Caloric VOR response has been associated with even-
tual recovery in several research and case studies (see Table 1 for
details) (28–30, 33, 34).
The second method involves electrical (galvanic) stimulation,
in which the signal can be modulated based on the research ques-
tion or clinical assessment goal, thus having a greater versatility
than the traditional caloric stimulation method (34). This has
been used by one group to assess patients in VS and MCS (34).
They found that quantitative VOR response from galvanic stim-
ulation recorded using a computer was able to stratify clinical
outcome for a group of five comatose patients all with GCS of
3 on admission (34). Although only limited conclusions can be
drawn from five cases, it illustrates the potential for computer-
based eye tracking for measuring VOR in patients who have a low
responsiveness and arousal. More studies are needed to demon-
strate how specific these effects are between MCS and VS patients.
Not all research positively suggested that VOR is effective in DOC
assessment, however. Yagi and Baba (27) investigated 86 comatose
patients using caloric VOR and auditory–brainstem responses
(ABR) (an electrode-based measurement). They found that the
ABR was more effective in predicting outcome in coma, but not
all patients who were unable to exhibit VOR had a poor outcome
(27). All considered, VOR could be a robust tool for assessment
and prognosis in DOC, and is currently the eye measurement of
choice compared to other movement types.
VISUAL FIXATION AND PURSUIT
Visual fixation and pursuit are the second most feasible measure
of eye movement in DOC. Successful visual fixation is indicative
of functional recovery (43). Furthermore, previous research have
measured visual pursuit and tracking with high throughput eye
trackers and there is evidence suggesting that VT performance can
effectively differentiate between MCS and VS states. For example,
Trojano et al. (35) conducted an experiment where moving shape
stimuli were connected to a computerized eye tracker to assess the
characteristics of visual tracking in 9 VS, 9 MCS, and 11 healthy
control participants. They found that the proportion of off-target
to on-target fixations were significantly different between the VS
and MCS patients. Furthermore, there was a clear qualitative dif-
ference in the path of visual tracking between the three groups that
could easily be identified by a clinician or nurse. Although simple
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Table 1 | Literature investigating eye movement measurement in disorders of consciousness.
Citation Sample size and DOC Clinical utility
of eye movements
measurement
Relevant eye
movement
measured
Primary relevant outcome
SECTION 1: PRIMARY RESEARCH STUDIES
Trojano et al. (35) 9 VS; 9 MCS; 11 HC + VT On-target fixation proportion is different between
MCS and VS
Weiss et al. (33) 26 VS + Caloric horizontal
VOR, NY
Fast component of NY during VOR present in all
patients who recovered consciousness; only one
present in patients who remained unconscious
Candelieri et al. (36) 9 VS; 13 MCS + VP VP elicited in 62% MCS but only 33% VS; VP activity
fluctuates over a day
Dolce et al. (37) 395 VS + VT VT in 73% of VS patients; appearance of VT indicative
of higher GOS outcome
Bruno et al. (38) 10 VS; 39 HC [N] VF VS patients exhibited altered PET metabolic
dysfunction compared to HC; VF +ve metabolism did
not differ from VF −ve metabolism
Balazs et al. (39) 14 PVS + SBEM PVS plus recovery patients show stronger pre-slow
ballistic eye movement gamma minimum than PVS
minus recovery patients
Schlosser et al. (34) 5 CO (All GCS 3) + Galvanic VOR Patient with no response to galvanic stimulation later
brain dead; patients with spontaneous and VOR
response to galvanic stimulus later recovered
Oksenberg et al. (40) 11 VS; 6 HC − Sleep REM
phasic activity
REM phasic activity in VS unrelated to recovery
van den Berge et al. (31) 30 CO [N] Inter-rater
reliability of
VOR-caloric
Kappa within range of 0.46–0.49, indicating moderate
agreement
Mueller-Jensen et al. (30) 81 CO + Oculocephalic
response, VOR
Absence of VOR is indicative of −ve outcome;
presence of VOR is indicative of +ve outcome, 67%
of the time
Born et al. (29) 109 sustained LOC
(GCS ≤7)
+ Oculocephalic
response, VOR
Via logistic discriminant analysis of outcome,
integration of VOR into assessment improves
outcome prediction at 6 months
Yagi and Baba (27) 86 CO − Caloric VOR Auditory–Brainstem Response (non-eye) was more
effective than caloric VOR in prognosis of CO patients.
Furthermore, not all patients who lacked VOR
response had poor outcome
Braakman et al. (41) 305 CO + Reflex and
spontaneous
reflex eye
movement
Reflexive and spontaneous eye movement is
predictive, along with age in decades, duration of
coma, GCS score, and pupillary response of GOS
outcome in CO patients 6 months later
SECTION 2: CASE STUDIES/SERIESAND LETTERS
Trojano et al. (42) 13 VS/UWS, 13 MCS;
13 HC
+ VT MCS patient ratio of on-target:off-target fixation for
pictures of participants’ relatives higher than circle or
parrot stimulus. Proportion of on-target fixation in VS
below chance; in MCS above chance
(Continued)
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Table 1 | Continued
Citation Sample size and DOC Clinical utility
of eye movements
measurement
Relevant eye
movement
measured
Primary relevant outcome
Schnakers et al. (43) 60 post-CO; of these,
29 VS, 7 MCS
+ CRS-R Scaled assessment of visual tracking in CRS-R more
sensitive than FOUR score, identified seven more
patients who were in MCS
Kane et al. (44) 60 CO + Ocular
micro-tremor
Oculogram Grade (OG) (based on graded assessment
of conjunctive micro-tremor) positively correlated with
GCS score at time of assessment and GOS outcome
at 3 months
Leigh et al. (28) 6 CO, 4 PVS, 6 HC + Oculocephalic
response brought
by VOR
Post-VOR midline drift time constant ≥10 s in HC;
≤1.5 s in sLoC; ≤0.5 in PVS
van Woerkom et al. (45) 1 CO; 60 TBI patients
later in DOC
+ Caloric
nystagmus
Abnormal saccadic oscillations in 10 TBI patients
associated with poor GOS 1/6 months post-injury
MCS, minimally conscious state; VS, vegetative state; PVS, persistent vegetative state; UWS, unresponsive wakefulness syndrome; CO, comatose state; sLoC,
sustained loss of consciousness; pt/pts, patient(s); HC, healthy control; SCC, saccade; VOR, vestibulo-ocular reflex; VP, visual pursuit; VF, visual fixation; VT, visual
tracking; SBEM, Slow Ballistic Eye Movement; REM, Rapid Eye Movement; NY, Nystagmus; [N], Neutral;TBI, traumatic brain injury; GCS, Glasgow Coma Scale; GOS,
Glasgow Outcome Score; FOUR, Full Outline of UnResponsiveness Scale; CRS-R, Coma Recovery Scale-Revised.
assessment of visual fixation does not require eye-tracking tech-
nology, this is an example of how the technology can help make
assessments more precise, accurate, and effective.
Candelieri et al. (36) studied visual pursuit in 9 VS and 13
MCS patients using the scaled CRS-R, and found that in 63% of
MCS patients effective visual pursuit could be elicited, whereas
only 33% of VS patients were able to initiate them. They were also
one of the first to report that visual pursuit performance fluctu-
ates over the day in DOC patients. Finally, a study by Bruno et al.
(38) coupled advanced neuroimaging with scaled visual tracking
as measured by the CRS-R. They found that patients in the VS had
altered metabolic function in PET neuroimaging compared with
the healthy control group. Studies discussed here, which quanti-
tatively measured visual tracking behavior, used simple measures
such as the proportion of successful visual tracking time on-target
or off-target. However, many other variables can be obtained from
a computerized trace, and future studies could delve more deeply
to identify more sensitive and specific biomarkers of conscious
state in these patients with the data obtained from the eye-tracking
technology.
SACCADES AND RAPID EYE MOVEMENTS
Rapid eye movements (REMs) such as saccades allow us to quickly
focus on objects in our environment. The saccadic generation
system is well characterized in humans (13, 14, 16). Signal gen-
eration and final integration of the oculomotor command takes
place in the brainstem, but upstream modulatory centers in the
midbrain (superior colliculi) and cerebral cortices (frontal and
parietal eye fields) play critical roles in the accurate generation
of different types of saccades (19, 46). Saccades can be generated
from memory, in response to novel visual stimuli, or directed away
from a certain novel visual stimulus (19). The saccadic system is
well integrated between different levels of neural control. Further-
more, highly portable saccadometers have been designed that can
be worn on the patient’s head, with the visual stimulus projected
onto a white wall (47).
Saccades would be the ideal system of eye movement to mea-
sure, since they are readily quantifiable and have mapped neu-
roanatomical substrates. However, reliable measurement of sac-
cades in response to memory or novel visual stimuli is difficult in
DOC patients because many experimental paradigms require con-
scious awareness. There has been little research looking specifically
at saccadic measures in DOC, except for quick saccadic oscilla-
tions (39). Microsaccades (small involuntary jerks of the eye) may
be useful as an alternative for eye movement assessment of visual
attention in the future (48–50), but their role in DOC, if any, have
yet to be established.
OTHER EYE MOVEMENTS – QUICK PHASES OF NYSTAGMUS, OCULAR
MICRO-TREMORS, REM
Nystagmus is an involuntary eye movement associated with sac-
cades requiring little cortical integration, which has been used in
the assessment of DOC patients after VOR stimulation (45). Ocu-
lar micro-tremors (discussed in more detail below) have also been
investigated in DOC patients with analog machinery, but not with
computerized eye-tracking software (44). Very few research stud-
ies have measured REM during sleep in VS patients. Oksenberg
et al. (40) conducted a study with 11 VS and 6 healthy con-
trol participants, but did not find a significant relationship with
recovery (40).
VALIDATION OF EYE MOVEMENT MEASUREMENT IN DOC
Only one study was found to assess reliability of eye movement
measurement in DOC, and no studies assessing validity were
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identified. van den Berge et al. (31) assessed the inter-rater reliabil-
ity of vestibulo-ocular reflex monitoring in 30 comatose patients
(31). This study used a scaled measure of VOR from one (no reac-
tion) to four (full nystagmus). The VOR responses were recorded
on film and analyzed after the experiment by experienced neurol-
ogists. The kappa (inter-rater reliability) ratings for spontaneous
eye movements and oculocephalic responses were 0.46 and 0.49,
respectively indicating moderate agreement (31). More studies
investigating the sensitivity, specificity, reliability, and validity of
eye movements measurement in DOC patients are required if these
methods are to gain widespread acceptance in medical practice.
CASE STUDIES, CASE SERIES, AND LETTERS
Overall, there have been few clinical case studies and letters inves-
tigating eye movement measurement in DOC. Trojano et al. (42)
conducted a study in which 13 VS, 13 MCS, and 13 healthy con-
trol participants viewed circles, parrot pictures, and pictures of
their relatives as stimuli in an eye-tracking paradigm for visual
pursuit and tracking (42). They found that in MCS patients, the
ratio of on-target to off-target fixations for pictures of their rela-
tives was higher than for the other two stimuli, indicating there is
some visual processing and affective salience associated with the
picture that is not present in VS patients (42). A natural progres-
sion from this study would be to investigate multi-sensory stimuli,
which may combine auditory and visual domains, for example,
for a more nuanced approach and enhanced sensitivity to detect
differences between MCS and VS patients.
Schnackers et al. conducted a study in 2006 in which 60 post-
comatose patients (of these, 29 VS and 7 MCS) were graded
according to the CRS-R. They found that scaled assessment of
visual tracking was more sensitive in the CRS-R to outcome than
the Full Outline of UnResponsiveness (FOUR) score, which has
less detailed eye response assessment (43). Here, we see the advan-
tage of scaled assessment over simple appraisal of eye movement;
a similar advantage can be gained when considering electronic eye
movement measurement over scaled responses.
Kane et al. (44) reported a case series of 60 comatose patients
whose ocular micro-tremor was assessed using an electrooculo-
gram. By creating an “oculogram score” from the recorded eye
tracings based on the level of conjunction of eye movement, they
correlated ocular micro-tremor activity with GCS score at time
of recording and GOS score at 3 months, with positive results
(44). Leigh et al. (28) found that temporal characteristics of the
post-VOR midline drift back to center could differentiate healthy
controls, patients in persistent VS, and coma (28). As early as 1984,
van Woerkom et al. reported that abnormal saccadic oscillations
associated with caloric stimulation in TBI patients was associ-
ated with poor GOS outcome 1 and 6 months post-injury (45).
Most of these examples have shown that quantitative measure-
ment of eye movements has clinical utility either in diagnosing
DOC or in assessing long-term prognosis of these patients. Table 1
summarizes our findings.
TRENDS IN EYE-TRACKING TECHNOLOGY
All types of eye movement responses are easily measured using
a modernized computerized eye tracker, including VOR, visual
fixation, smooth pursuit, nystagmus, and saccades. Commercial
companies have developed advanced eye-tracking systems for use
in research, such as the EyeLink® 1000 by SR Research (51) or
the IVIEW XTM High Speed Eye Tracker by SensoMotoric Instru-
ments (52). These high speed advanced eye trackers are able to
measure many parameters at once with sub-millisecond tempo-
ral resolution and spatial precision to within a 10th of a degree,
all with sampling frequencies in the thousands of hertz (51).
Recent developments such as the IRIS Infrared Limbus Eye Tracker
(53) by Skalar and the Portable Saccadometer by Ober Con-
sulting (47) have introduced head-mounted eye tracking, which
increases portability of the instrument and feasibility for clini-
cal adoption. Many of the advanced systems are programable and
the portable units allow measurement parameters (i.e., stimulus
latency, location, frequency) to be tailored for clinical applications.
With technological progress, we have been able to measure
spontaneous eye movements or ocular responses to stimuli with
greater accuracy and precision. Since the 1990s, analog eye-
tracking technology such as the electrooculograph has gradually
been replaced by digital methods connected to high throughput
computers. Furthermore, a clear trend has emerged toward minia-
turization and enhanced temporal/spatial fidelity. Over time, these
trends are expected to continue, such that advanced eye tracking
will be easier to integrate into clinical practice by eliminating phys-
ical barriers such as size and portability while maintaining high
quality for research or clinical applications. We expect these trends
to continue with advances in wearable consumer technology (e.g.,
Google Glass analogs, fitness trackers, smartwatches).
RESEARCH PERSPECTIVES AND FUTURE DIRECTIONS
Currently, there are a limited number of studies supporting these
measurements in clinic environment, and only one validation
study has been found in MEDLINE. Despite this, the available
evidence is compelling. The results of the literature review sug-
gest that majority of the eye movement recording conducted in
research currently are limited to VOR or other simple responses,
which are quick to conduct, quantify, and interpret. In the future,
however, as battery life associated with portable technology is
extended, we should see the emergence of long-term eye-tracking
studies, which may detect patterns over extended periods of time
(over the course of several days, weeks, or months) unfeasible with
current devices. This will open new domains in research and clin-
ical decision making for these patients, since patterns may emerge
from protracted, natural eye-tracking recording in patients, which
is not detectable in short timepoints.
PRACTICAL PERSPECTIVES
Currently used approaches such as the GCS or the FOUR score are
effective and are simple and quick enough to perform while still
being sufficient to make diagnostic decisions. The eye trackers that
are clinically useful today, much like the useful computers of sev-
eral decades ago, are large and unwieldy, requiring the patient to be
in a specific body position (e.g., sitting upright) and are not suited
for use in patients with secondary neck injuries due to head trauma
(limited neck movement). With more robust research, results sup-
porting the use of eye tracking in assessing DOC in the future, in
tandem with the miniaturization trends discussed earlier, we see
that the practical benefits of improved outcome assessment will
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outweigh the costs associated with adopting new technology and
framework for assessment. Neuroimaging went through a similar
process from clinical acceptance to adoption since its development
several decades ago, but it is now part of routine clinical assessment
and care. A similar level of research and development needs to take
place for advanced eye measurement in DOC patients moving for-
ward. Currently, another important barrier to clinical adoption
include limited validation studies demonstrating the diagnostic
power of eye movement measurement in DOC, as discussed ear-
lier. These developments and studies will likely need to take place
before we can expect to see widespread clinical adoption of eye
movement assessment.
The clinical and research ethics councils in health organiza-
tions need to discuss issues of patient consent and develop a
framework for deployment of these tools, but integration of eye-
tracking measurement tools should not completely replace what
is currently available. There is critical value in the clinical assess-
ment and the physician’s appraisal of conscious state. Although
eye movement measurements may prove to be an effective diag-
nostic tool, training critical care physicians and nurses for more
thorough neurological examinations and clinical expertise is still
very important and is likely to have the largest immediate impact
on reducing misdiagnosis rate. A clinician’s judgment obtained
from time-tested tools should not be replaced, but further aug-
mented by this technology. In the final analysis, integration and
adoption of eye-tracking tools and methods should not be a bar-
rier, but rather a helpful aid toward better care and reduction of
misdiagnosis for any patient in a DOC.
LIMITATIONS
There are limitations to our literature search and interpretation.
We only reviewed results from Ovid MEDLINE. Study quality was
not systematically assessed. Diagnostic randomized controlled tri-
als were not found (54), which might identify whether eye-tracking
assessment provides any advantage over the contemporary gold
standard of behavioral assessment. Finally, there were very few
studies which quantitatively assessed the prognostic ability of eye
tracking in DOC (see Table 1). Although some studies performed
correlational analyses between measurement and GOS outcome,
more studies along this avenue are needed to see if eye tracking
has any prognostic relevance or if it is only useful as a diagnostic
classifier.
CONCLUSION
AN INTEGRATED PERSPECTIVE
Richer information about how eye movement/response is affected
will be instrumental in advancing clinical assessment of DOC in
the future. As medical technology becomes quicker, more accurate,
and miniaturized, the integration of advanced measurement tools
like the ones discussed into our daily lives will quickly become
seamless. It is imperative, therefore, that a clinical framework be
set in place early so that the implementation of these tools in medi-
cine is not a barrier unto itself. Creating a strategic plan integrating
economic, research, logistic, and ethical aspects is essential for suc-
cessful transition from simple appraisals of eye response, through
scaled assessment of eye movement, to widespread adoption of
quantitative eye measurement by the bedside.
A VISION FOR THE FUTURE
We can envision a future in which technology to measure eye
movements is embedded into the process of medicine so well that
it becomes invisible – physicians will have crucial human inter-
actions with patients, but their judgment will be aided by semi-
autonomous measurement machines, which track eye movements
over their entire stay in the hospital, and generate a report with
recommended diagnostics and projected clinical outcome. Clin-
ical decision making can be augmented through a standardized
and validated scale based on simplifying heuristics obtained from
the eye-tracking device. All of this tracking will be conducted with
minimal physician input. The eye-tracking machine itself could
take the form of a wireless contact lens that the patient wears, offer-
ing the optimum combination of portability, power, sensitivity,
and non-invasiveness. This vision may not be too far off – innova-
tors in silicon valley have already developed eye-tracking add-ons
for Google Glass, the de facto vanguard in wearable computing
today (55).
In conclusion, research evidence supports integration of quan-
titative eye movement measurement in improving diagnostic pre-
cision in of DOC. However, more validation studies are required
to assess prognostic relevance of eye tracking. It will also require
a coordinated effort between disciplines between frameworks
of medicine and research to bring this beneficial assessment
methodology to clinical care of DOC.
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APPENDIX
Ovid MEDLINE was searched for peer-reviewed literature meeting
specific inclusion/exclusion criteria.
INCLUSION
Primary clinical studies/case series/letters.
Study conducted in humans.
Patient group must have sustained pathological sustained loss of
consciousness (VS, PVS, MCS, or Coma).
Measurement must be quantitative or scaled and conducted
during DOC.
Abstract or full text written in English.
EXCLUSION
Duplicate results
Loss of consciousness due to intoxication (intoxication itself may
adversely affect eye movements).
Non-pathological loss of consciousness (e.g., sleep, g-forced
induced, anesthesia, Valsalva maneuver loss of consciousness
studies).
Studies of locked-in syndrome (patients present with high
arousal and awareness).
Study published prior to 1980.
Reviews or Opinion Articles.
MEDLINE Search Algorithm
Ovid Medline was queried on 20 November 2013 as follows.
Database: Ovid MEDLINE(R) (1946 to November Week 1
2013), Ovid MEDLINE(R) In-Process and Other Non-Indexed
Citations (November 19, 2013).
Search strategy:
exp consciousness disorders/ or exp consciousness/(44522)
exp eye movements/(39713)
1 and 2 (313)
remove duplicates from 3 (308)
limit 4 to (English language and humans and year =“1980−
Current”) (130)
limit 5 to “review” (20)
5 not 6 (110).
Each abstract was screened with full-text if available. Studies
which did not fulfill the inclusion criteria, met the exclusion cri-
teria, or studies for which the full text was not available and the
abstract alone was insufficient were removed (N = 91). Five articles
were automatically removed as duplicates during the search. Thir-
teen primary research studies were included in the final review.
Five case studies and letters were also included, but grouped
separately in Table 1.
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